NFKB1 and diffuse large B-cell lymphoma: It has been established that DLBCL, although genetically heterogeneous, can be robustly divided at the gene expression level into two “cell of origin” (COO) subgroups based on markers of B-cell differentiation and NF-κB activity pathways, where high NF-κB activity is a hallmark of the ABC subgroup1.